Related Experiment Video
Updated: Jun 13, 2026
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease
Zongyuan Liu1,2, Rebecca Ulrich vonBargen2,3, April L Kendricks4
1Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, USA.
Insights
Chagas disease treatment with immunotherapy plus benznidazole improves cardiac small molecule restoration more than benznidazole alone. This finding offers new insights into treating infectious disease sequelae and treatment failure.
Area of Science:
- Parasitology
- Immunology
- Molecular Biology
Background:
- Post-infectious conditions like Chagas disease (CD) pose significant health challenges.
- Current antiparasitic treatments for CD, caused by Trypanosoma cruzi, do not always lead to improved clinical outcomes despite parasite clearance.
Purpose of the Study:
- To investigate small molecule changes in cardiac regions during chronic Chagas disease.
- To compare the efficacy of benznidazole monotherapy versus a combination therapy (reduced-dose benznidazole plus immunotherapy) in restoring cardiac small molecule profiles.
Main Methods:
- Analysis of differential small molecule trajectories in cardiac regions of infected animals.
- Assessment of cardiac small molecule restoration following benznidazole treatment.
- Evaluation of cardiac small molecule restoration following combination therapy.
Main Results:
- Differential small molecule changes were observed in cardiac regions, correlating with Chagas disease apical aneurysm sites.
- Benznidazole treatment resulted in incomplete and region-specific restoration of cardiac small molecules.
- Combination therapy demonstrated superior restoration of the cardiac small molecule profile compared to benznidazole alone, even with reduced parasite burden.
Conclusions:
- The study reveals molecular mechanisms underlying Chagas disease treatment, highlighting the importance of targeting both the pathogen and host small molecule responses.
- Understanding persistent small molecule perturbations post-infection is crucial for addressing treatment failure in Chagas disease and other infectious sequelae.
Abstract:
Post-infectious conditions present major health burdens but remain poorly understood. In Chagas disease (CD), caused by Trypanosoma cruzi parasites, antiparasitic agents that successfully clear T. cruzi do not always improve clinical outcomes. In this study, we reveal differential small molecule trajectories between cardiac regions during chronic T. cruzi infection, matching with characteristic CD apical aneurysm sites. Incomplete, region-specific, cardiac small molecule restoration is observed in animals treated with the antiparasitic benznidazole. In contrast, superior restoration of the cardiac small molecule profile is observed for a combination treatment of reduced-dose benznidazole plus an immunotherapy, even with less parasite burden reduction. Overall, these results reveal molecular mechanisms of CD treatment based on simultaneous effects on the pathogen and on host small molecule responses, and expand our understanding of clinical treatment failure in CD. This link between infection and subsequent persistent small molecule perturbation broadens our understanding of infectious disease sequelae.
